RecruitingPhase 2NCT05052957

hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)

Studying Gliosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Leland Metheny
Principal Investigator
Leland Metheny, MD, MD
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Intervention
P140K-MGMT(biological)
Enrollment
16 enrolled
Eligibility
18-75 years · All sexes
Timeline
2023 – 2026

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05052957 on ClinicalTrials.gov

Other trials for Gliosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Gliosarcoma →

← Back to all trials